Houdini Bio
1 known investors
Houdini Bio develops a DNA design platform using synthetic biology and machine learning to improve genetic medicines. The platform redesigns therapeutic DNA to escape cellular silencing pathways, enabling greater durability, safety, and cost-effectiveness for genetic medicine treatments.